Literature DB >> 20636866

Evaluation of the effect of topical agents on radiation-induced skin disease by reflectance spectrophotometry.

Luisa Rizza1, Antonio D'Agostino, Andrea Girlando, Carmelo Puglia.   

Abstract

OBJECTIVES: Radiotherapy may cause severe skin changes that significantly interfere with the patient's quality of life and reduce radiotherapy effectiveness. Many skin care instructions and various topical agents are recommended to help patients in the management of radiation skin reactions, but evidence to support the value of the topical treatments of the irradiated skin is lacking. In the present study we investigated the effects of topical agents used as supportive care to minimise radiation-induced skin disease using an instrumental method.
METHODS: Subjects who were undergoing a planned course of radiation therapy after breast-conserving surgery were randomised to treatment (using one of two topical agents) or non-treatment (control) groups and monitored over 8 weeks. The intensity of skin erythema was evaluated once per week by non-invasive instrumental reflectance spectrophotometry in comparison with a visual scoring system. KEY
FINDINGS: Examination of the erythema time course by a sensitive spectrophotometric reflectance method showed a significant increase of skin reactions in the non-treated group after the second week of treatment and maximal alterations between the fourth and sixth week.
CONCLUSIONS: From the results obtained, we observed that application of topical agents used in radio-induced skin disease were able to significantly reduce the erythema extent compared to the non-treated group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636866     DOI: 10.1211/jpp.62.06.0015

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

Review 1.  Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.

Authors:  Rebecca K S Wong; René-Jean Bensadoun; Christine B Boers-Doets; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2013-08-14       Impact factor: 3.603

2.  Complementary and alternative medicine in reducing radiation-induced skin toxicity.

Authors:  Jennifer J Hu; Tengjiao Cui; Jorge L Rodriguez-Gil; Glenn O Allen; Jie Li; Cristiane Takita; Brian E Lally
Journal:  Radiat Environ Biophys       Date:  2014-05-05       Impact factor: 1.925

Review 3.  Topical agent therapy for prevention and treatment of radiodermatitis: a meta-analysis.

Authors:  Yuejiao Zhang; Shoude Zhang; Xiaoling Shao
Journal:  Support Care Cancer       Date:  2012-10-12       Impact factor: 3.603

Review 4.  Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Raymond Javan Chan; Joan Webster; Bryan Chung; Louise Marquart; Muhtashimuddin Ahmed; Stuart Garantziotis
Journal:  BMC Cancer       Date:  2014-01-31       Impact factor: 4.430

5.  Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model.

Authors:  Elina Korpela; Darren Yohan; Lee Cl Chin; Anthony Kim; Xiaoyong Huang; Shachar Sade; Paul Van Slyke; Daniel J Dumont; Stanley K Liu
Journal:  BMC Cancer       Date:  2014-08-26       Impact factor: 4.430

6.  Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model.

Authors:  Lee Chin; Elina Korpela; Anthony Kim; Darren Yohan; Carolyn Niu; Brian C Wilson; Stanley K Liu
Journal:  J Vis Exp       Date:  2016-05-27       Impact factor: 1.355

7.  Efficacy of heparinoid moisturizer as a prophylactic agent for radiation dermatitis following radiotherapy after breast-conserving surgery: a randomized controlled trial.

Authors:  Kenji Sekiguchi; Keiko Akahane; Mami Ogita; Chiori Haga; Ryoko Ito; Satoru Arai; Yasushi Ishida; Yoichiro Tsukada; Jiro Kawamori
Journal:  Jpn J Clin Oncol       Date:  2018-05-01       Impact factor: 3.019

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.